Neurocrine Biosciences
NBIX
#1649
Rank
A$18.36 B
Marketcap
A$182.61
Share price
-0.75%
Change (1 day)
12.61%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company